Abstract

HIRUDOTHERAPY BY AVICENNA'S METHODS IN TREATMENT OF CHRONIC HEART FAILURE AT ISCHEMIC HEART DISEASE PATIENTS WITH THE INCREASED ARTERIAL BLOOD PRESSURE

*Qodirova Shakhlo Salomovna and Djabbarova Miyassar Babakulovna

Abstract

Now the principles of drug treatment of the chronic heart failure (CHF) meaning normalization of an intracardial and central hemodynamics, microcirculation, activity of neurohumoral systems of an organism, prevention and therapy of disturbances of a heart rhythm, sudden cardiac death, thromboembolic syndrome are defined (BelenkovYu.A., MareevV.Yu., 2000; Braunvald E. et al., 2005). Wide use of ACE inhibitor, blockers of adrenergic receptors, diuretics allowed to improve considerably quality and life expectancies of patients with chronic heart failure. Despite obvious achievements of the last years in the field of studying of a pathogeny, diagnostics and treatment, chronic heart failureremains widespread, heavy and predictively an adverse complication of many diseases of a cardiovascular system (Almazov V. A., Shlyakhto E.V., 2001; Cleland J., 2004). The prevalence of chronic heart failureconstantly grows and is in the European population from 0.4% to 2% (Cowie M.R. et al., 1997). In Russia in 2002 revealed more than 8 million patients with clinical manifestations of chronic heart failure(Belenkov Yu. N and соав., 2003).

Keywords: Hirudotherapy, intracardial, hemodilution, hepatomegalias, hemostasis, acrocyanosis.